vincristinsulfat 1mg hexal süstelahus
salutas pharma gmbh - vinkristiin - süstelahus - 1mg 1ml 1ml 1tk
cytosar süstelahuse pulber
pfizer europe ma eeig - tsütarabiin - süstelahuse pulber - 1000mg 1tk
cytosar süstelahuse pulber ja lahusti
pfizer europe ma eeig - tsütarabiin - süstelahuse pulber ja lahusti - 500mg 1tk
vinblastine teva süstelahus
teva pharma b.v. - vinblastiin - süstelahus - 1mg 1ml 10ml 1tk
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.